Big News Gains: ARC Group Worldwide (NASDAQ:ARCW), SCYNEXIS (NASDAQ:SCYX), Pfizer (NYSE:PFE), Clayton Williams Energy (NYSE:CWEI)

Posted by on Apr 08, 2016

Juno Therapeutics Inc. (NASDAQ:JUNO) shares decreased -3.29% in last trading session and ended the day at $40.85. JUNO has a return on assets of -24.30%. Juno Therapeutics Inc. (NASDAQ:JUNO) quarterly performance is 4.08%.

Juno Therapeutics (NASDAQ: JUNO) and WuXi AppTec, a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries, announced that they have started a new company in China. JW Biotechnology (Shanghai) Co., Ltd’s mission is to build China’s leading cell therapy company by leveraging Juno’s world-class chimeric antigen receptor (CAR) and T cell receptor (TCR) technologies together with WuXi AppTec’s R&D and manufacturing platform and local expertise to develop novel cell-based immunotherapies for patients with hematologic and solidorgan cancers. James Li, M.D., formerly a Kleiner Perkins partner and General Manager of Amgen China, and a JW Biotechnology (Shanghai) Co., Ltd co-founder, has been appointed Chief Executive Officer of JW Biotechnology (Shanghai) Co., Ltd.

ARC Group Worldwide, Inc. (NASDAQ:ARCW) ended the last trading day at $2.25. Company weekly volatility is calculated as 8.27% and price to cash ratio as 10.85. ARC Group Worldwide, Inc. (NASDAQ:ARCW) showed a weekly performance of -10.00%.

ARC Group Worldwide, Inc. (NASDAQ:ARCW), a leading global provider of advanced manufacturing and 3D printing solutions, announced that it has appointed Mr. Alan G. Quasha as Chairman of the Board. Mr. Quasha is the Chief Executive Officer of Quadrant Management, Inc. (“QMI”), a principal investment management firm he founded in 1978. Through QMI, Mr. Quasha has started, purchased, and built dozens of businesses across the U.S. and international markets. Mr. Quasha has deep expertise in the manufacturing industry, among various other industries.

On 07 April, SCYNEXIS, Inc. (NASDAQ:SCYX) shares increased 2.36% and was closed at $4.13. SCYNEXIS, Inc. (NASDAQ:SCYX) year to date (YTD) performance is -33.57%.

Drug development company SCYNEXIS, Inc. (NASDAQ:SCYX) announced that the Company will present at the 15th Annual Needham Healthcare Conference at The Westin Grand Central Hotel in New York City on Wednesday, April 13, 2016 at 12:10 p.m. ET.

Pfizer Inc. (NYSE:PFE) shares decreased -0.52% in last trading session and ended the day at $32.76. PFE Gross Margin is 80.40% and its has a return on assets of 5.70%. Pfizer Inc. (NYSE:PFE) quarterly performance is 4.68%.

The biggest US-based drugmaker, Pfizer Inc, (NYSE:PFE) will stay put thanks to aggressive new Treasury Department rules that succeeded in blocking Pfizer from acquiring rival Allergan and moving to Ireland – on paper – to reduce its tax bill. Pfizer cited Treasury’s new regulations, issued late Monday, to make such “tax inversions” less lucrative.

Clayton Williams Energy, Inc. (NYSE:CWEI) caters to the Basic Materials space. It has a net profit margin of -42.30% and weekly performance is 47.31%. On the last day of trading company shares ended up at $13.14. Clayton Williams Energy, Inc. (NYSE:CWEI) distance from 50-day simple moving average (SMA50) is 3.74%.

On 31st March, Clayton Williams Energy, Inc. (NYSE:CWEI) announced the resignation of Robert L. Parker from the Company’s Board of Directors (the “Board”) effective March 30, 2016. Mr. Parker had served as a director of the Company since 1993 and at the time of his resignation served as chairman of the audit committee and served on the compensation committee and the nominating and governance committee.

Leave a Reply

Your email address will not be published. Required fields are marked *